Tolerability and safety of olive oil-based lipid emulsion in critically ill neonates: A blinded randomized trial

Nutrition

Volumn 24, Issue 11-12, 2008, Pages 1057-1064

  Webb, Annette N ^a,b   Hardy, Pollyanna ^a   Peterkin, Megan ^a   Lee, Olive ^b   Shalley, Helen ^a   Croft, Kevin D ^c   Mori, Trevor A ^c   Heine, Ralf G ^a,b,d   Bines, Julie E ^a,b,d  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Lipid emulsions; Neonates; Olive oil; Parenteral nutrition; Soybean oil

Indexed keywords

CLINOLEIC; FATTY ACID; INTRALIPID; ISOPROSTANE DERIVATIVE; LINOLEIC ACID; LIPID EMULSION; OLEIC ACID; OLIVE OIL;

ARTICLE; CLINICAL TRIAL; CONGENITAL DIAPHRAGM HERNIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DRUG SAFETY; DRUG TOLERABILITY; ESOPHAGUS ATRESIA; FEMALE; GASTROSCHISIS; HEART FAILURE; HUMAN; INFANT; INTESTINE ATRESIA; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; NECROTIZING ENTEROCOLITIS; NEUROLOGICAL COMPLICATION; PARENTERAL NUTRITION; PARVOVIRUS INFECTION; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UMBILICAL HERNIA;

CRITICAL ILLNESS; DOUBLE-BLIND METHOD; F2-ISOPROSTANES; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS; FEMALE; HUMANS; INFANT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; INFANT, NEWBORN; LINOLEIC ACID; LIVER; MALE; OLEIC ACID; PARENTERAL NUTRITION; PHOSPHOLIPIDS; PLANT OILS; SOYBEAN OIL; TREATMENT OUTCOME;

GLYCINE MAX;

EID: 53449093728     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2008.05.004     Document Type: Article

References (47)

1. Lehner F., Demmelmair H., Roschinger W., Decsi T., Szasz M., Adamovich K., et al. Metabolic effects of intravenous LCT or MCT/LCT lipid emulsions in preterm infants. J Lipid Res 47 (2006) 404-411
2. Goulet O., de Potter S., Antebi H., Driss F., Colomb V., Bereziat G., et al. Long-term efficacy and safety of a new OO-based intravenous fat emulsion in pediatric patients: a double-blind randomized study. Am J Clin Nutr 70 (1999) 338-345
3. Koletzko B. Parenteral lipid infusion in infancy: physiology basis and clinical relevance. Clin Nutr 21 (2002) 53-56
4. Caresta E., Pierro A., Chowdhury M., Peters M.J., Piastra M., and Eaton S. Oxidation of intravenous lipid in infants and children with systemic inflammatory response syndrome and sepsis. Pediatr Res 61 (2007) 228-232
5. Koletzko B., Gobel Y., Engelsberger I., Peters J., Zimmermann A., Forget D., et al. Parenteral feeding of preterm infants with fat emulsions based on soybean and olive oils: effects on plasma phospholipid fatty acids. Clin Nutr 17 suppl 1 (1998) O.85
6. Innis S.M. Essential fatty acid requirements in human nutrition. Can J Physiol Pharmacol 71 (1993) 699-706
7. Innis S.M. The role of dietary n-6 and n-3 fatty acids in the developing brain. Dev Neurosci 22 (2000) 474-480
8. Uauy R., Hoffman D.R., Peirano P., Birch D.G., and Birch E.E. Essential fatty acids in visual and brain development. Lipids 36 (2001) 885-895
9. Haag M. Essential fatty acids and the brain. Can J Psychiatry 48 (2003) 195-203
10. Sala-Vila A., Barbosa V.M., and Calder P.C. Olive oil in parenteral nutrition. Curr Opin Clin Nutr Metab Care 10 (2007) 165-174
11. Wanten G.J., and Calder P.C. Immune modulation by parenteral lipid emulsions. Am J Clin Nutr 85 (2007) 1171-1184
12. Uauy R., Mena P., Wegher B., Nieto S., and Salem Jr. N. Long chain polyunsaturated fatty acid formation in neonates: effect of gestational age and intrauterine growth. Pediatr Res 47 (2000) 127-135
13. Buchman A.L., Iyer K., and Fryer J. Parenteral nutrition-associated liver disease and the role for isolated intestine and intestine/liver transplantation. Hepatology 43 (2006) 9-19
14. Ginn-Pease M.E., Pantalos D., and King D.R. TPN-associated hyperbilirubinemia: a common problem in newborn surgical patients. J Pediatr Surg 20 (1985) 436-439
15. Deckelbaum R.J. Intravenous lipid emulsions in pediatrics: time for a change?. J Pediatr Gastroenterol Nutr 37 (2003) 112-114
16. Rubin M., Moser A., Naor N., Merlob P., Pakula R., and Sirota L. Effect of three intravenously administered fat emulsions containing different concentrations of fatty acids on the plasma fatty acid composition of premature infants. J Pediatr 125 (1994) 596-602
17. Friedman Z., and Frolich C. Essential fatty acids and the major urinary metabolites of E-prostaglandins in thriving neonates and infants receiving parenteral fat emulsions. Pediatr Res 13 (1979) 932-936
18. Galli C., Agradi E., Petroni A., and Tremoli E. Differential effects of dietary fatty acids on the accumulation of arachidonic acid and its metabolic conversion through the cyclooxygenase and lipoxygenase in platelets and vascular tissue. Lipids 16 (1981) 165-172
19. Koletzko B. Lipid supply and metabolism in infancy. Curr Opin Clin Nutr Metab Care 1 (1998) 171-177
20. Keicher U., Koletzko B., and Reinhardt D. Omega-3 fatty acids suppress the enhanced production of 5-lipoxygenase products from polymorph neutrophil granulocytes in cystic fibrosis. Eur J Clin Invest 25 (1995) 915-919
21. Calder P.C. Fatty acid metabolism and eicosanoid synthesis. Clin Nutr 20 suppl 4 (2001) 1-5
22. Mori T.A., and Beilin L.J. Fatty acids and inflammation. Curr Atheroscler Rep 6 (2004) 461-467
23. Carpentier Y.A. Omega-3 fatty acids: from nutrition to pharmacological properties. Clin Nutr 20 suppl 4 (2001) 6-7
24. Endres S., Ghorbani R., Kelley V.E., Georgilis K., Lonnemann G., van der Meer J.W., et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 320 (1989) 265-271
25. Krohn K., and Koletzko B. Parenteral lipid emulsions in paediatrics. Curr Opin Clin Nutr Metab Care 9 (2006) 319-323
26. Alexander-North L.S., North J.A., Kiminyo K.P., Buettner G.R., and Spector A.A. Polyunsaturated fatty acids increase lipid radical formation induced by oxidant stress in endothelial cells. J Lipid Res 35 (1994) 1773-1785
27. Pitkanen O.M., Hallman M., and Andersson S.M. Correlation of free oxygen radical induced lipid peroxidation with outcome in very low birth weight infants. J Pediatr 116 (1990) 760-764
28. Sosenko I.R.S., and Rodriguez-Pierce M. Effect of early initiation of intravenous lipid administration on the incidence and severity of chronic lung disease in premature infants. J Pediatr 123 (1993) 975-982
29. Gobel Y., Koletzko B., Bohles H.J., Engelsberger I., Forget D., Le Brun A., et al. Parenteral fat emulsions based on olive and soybean oils: a randomized clinical trial in preterm infants. J Pediatr Gastroenterol Nutr 37 (2003) 161-167
30. van Kempen A.A., van der Crabben S.N., Ackermans M.T., Endert E., Kok J.H., and Sauerwein H.P. Stimulation of gluconeogenesis by intravenous lipids in preterm infants: response depends on fatty acid profile. Am J Physiol Endocrinol Metab 290 (2006) E723-E730
31. Pitkanen O.M., Luukkainen P., and Andersson S. Attenuated lipid peroxidation in preterm infants during subsequent doses of intravenous lipids. Biol Neonate 85 (2004) 184-187
32. Bines J., Titchen T., Humphrey M., and Jessen D. A practical guide to paediatric nutrition support (1997), Department of Gastroenterology and Clinical Nutrition, Royal Children's Hospital Victoria, Australia, Melbourne
33. Schofield D.A. Predicting basal metabolic rate. New standards and review of previous work. Hum Nutr Clin Nutr (1985) 542
34. Mori T.A., Bao D.Q., Burke V., Puddey I.B., Watts G.F., O'Neal D.N., et al. Purified eicosapentaenoic acid and docosahexaenoic acid have differential effects of on serum lipids and lipoproteins, LDL-particle size, glucose and insulin, in mildly hyperlipidaemic men. Am J Clin Nutr 71 (2000) 1085-1094
35. Mori T.A., Croft K.D., Puddey I.B., and Beilin L.J. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry. Anal Biochem 268 (1999) 117-125
36. Hennig B., Ennoch C., and Chow C.K. Linoleic acid hydroperoxides increases the transfer of albumin across cultured endothelial monolayers. Arch Biochem Biophys 248 (1986) 353-357
37. Hammerman C., and Aramburo M.J. Decreased lipid intake reduces morbidity in sick premature neonates. J Paediatr Child Health 113 (1988) 1083-1088
38. Iikkainen S. Olive oil based lipid emulsion decreases lipid peroxidation in newborns. Clin Nutr 21 suppl 1 (2002) 49
39. Halliwell B. Oxidative stress, nutrition and health. Experimental strategies for optimization of nutritional antioxidant intake in humans. Free Radic Res 25 (1996) 57-74
40. Antebi H., Zimmermann L., Bourcier C., Le Brun A., Guidicelli A., Dutot G., et al. In-vitro peroxidation and the effect of the administration of total parenteral nutrition with an olive-oil based lipid emulsion on the peroxidability of low-density lipoproteins in children. Nutr Clin Metabol 10 (1996) S41-S43
41. Kadiiska M.B., Gladen B.C., Baird D.D., Germolec D., Graham L.B., Parker C.E., et al. Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?. Free Radic Biol Med 38 (2005) 698-710
42. Morrow J.D., Hill K.E., Burk R.F., Nammour T.M., Badr II K.F., and Roberts L.J. A series of prostaglandin F2 like compounds are produced in vivo in humans by a non-cyclooxygenase free radical catalysed mechanism. Proc Natl Acad Sci U S A 87 (1990) 9383-9387
43. Lynch S.M., Morrow D.J., Roberts L.J., and Frei B. Formation of non-cyclooxygenase derived prostanoids (F2 isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro. J Clin Invest Med 93 (1994) 998-1004
44. Patrano C., and Fitzgerald G.A. Isoprostanes; potential markers of oxidant stress in atherothrombotic disease. Aterioscler Thromb Vasc Biol 17 (1997) 2309-2315
45. Lawson J.A., Rokach J., and Fitzgerald G.A. Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo. J Biol Chem 35 (1999) 24441-24444
46. Wood L.G., Fitzgerald D.A., Gibson P.G., Cooper D.M., and Garg M.L. Lipid peroxidation as determined by plasma isoprostanes is related to disease severity in mild asthma. Lipids 35 (2000) 967-974
47. Inder T., Mocatta T., Darlow B., Spencer C., Volpe J.J., and Winterbourn C. Elevated free radical products in the CSF of VLBW infants with cerebral white matter injury. Paediatr Res 52 (2002) 213-218